US 12156897
Magnesium-containing oxytocin formulations and methods of use
granted A61KA61K31/194A61K33/06
Quick answer
US patent 12156897 (Magnesium-containing oxytocin formulations and methods of use) held by TONIX PHARMA LIMITED expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TONIX PHARMA LIMITED
- Grant date
- Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/194, A61K33/06, A61K33/14, A61K38/095